文献速递物质与行为成瘾

性别与激素对成瘾药物线索反应性及其调节的影响

Sex and Hormonal Effects on Drug Cue Reactivity and Its Regulation in Human Addiction.
PubMed 文献 · Biol Psychiatry · 2025-05-27

结果发现,女性内侧前额叶皮层药物线索反应性更高,男性额眼区/背外侧前额叶药物重新评估更高且与较低线索诱导渴求相关;女性卵泡期额眼区/背外侧前额叶药物线索反应性高于黄体期,而黄体期前部前额叶/眶额皮层药物重新评估更高。雌二醇变化与腹内侧前额叶药物线索反应性变化正相关且与渴求变化相关,与腹内侧前额叶、前部前额叶和纹状体药物重新评估变化负相关;黄体期相对于卵泡期孕酮/雌二醇比值变化与背外侧前额叶药物重新评估变化正相关。结论提示女性HUD/CUD患者皮质纹状体药物线索反应性更高而前额叶药物重新评估活动更低,受卵泡期与黄体期及雌激素和孕激素波动影响,雌激素构成脆弱性而孕激素构成保护性因素。

要点

  • 女性HUD/CUD患者内侧前额叶药物线索反应性高于男性HUD患者。
  • 女性卵泡期药物线索反应性较高,黄体期药物重新评估较高。
  • 雌二醇变化与药物线索反应性正相关、与药物重新评估负相关。

核心结论

  • 与男性HUD患者相比,女性HUD/CUD患者表现出更高的皮质纹状体药物线索反应性和更低的前额叶药物重新评估活动。
  • 该效应由卵泡期相对于黄体期驱动,并与渴求及雌激素和孕激素波动直接相关。
  • 雌激素构成脆弱性因素,孕激素构成保护性因素,为开发精确计时和基于激素的治疗提供见解。

研究设计与样本

  • 使用功能磁共振成像(MRI)扫描,其中部分女性(HUD=3,CUD=13)在卵泡期晚期和黄体期中期接受两次扫描。

主要发现

  • 女性显示更高的内侧前额叶皮层药物线索反应性,男性显示更高的额眼区/背外侧前额叶药物重新评估,且与较低线索诱导药物渴求相关。
  • 女性卵泡期额眼区/背外侧前额叶药物线索反应性高于黄体期,黄体期前部前额叶/眶额皮层药物重新评估高于卵泡期。
  • 卵泡期相对于黄体期雌二醇变化越大,腹内侧前额叶药物线索反应性变化越高,且与更高药物渴求变化相关(在额下回也观察到)。
  • 雌二醇变化越大,腹内侧前额叶、前部前额叶和纹状体药物重新评估变化越低。
  • 黄体期相对于卵泡期孕酮/雌二醇比值变化与背外侧前额叶药物重新评估变化正相关。

临床怎么用

  • 针对女性HUD/CUD患者,可考虑根据月经周期阶段(卵泡期 vs 黄体期)和激素水平制定精确计时的个性化治疗。
  • 雌激素水平升高可能增加药物线索反应性和渴求,而孕激素可能增强药物重新评估,治疗干预可考虑激素知情策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The underlying corticostriatal mechanisms of sex and hormonal effects in addiction are unknown, limiting the development of personalized treatments. METHODS: Thirty-two women (age = 38.85 ± 9.84 years) with heroin use disorder (HUD) or cocaine use disorder (CUD) (HUD = 16; CUD = 16) and 49 age-matched men (age = 41.96 ± 9.71 years) with HUD were scanned using functional magnetic resonance imaging (MRI), with a subgroup of women (HUD = 3; CUD = 13) scanned twice, during the late-follicular and mid-luteal phases. RESULTS: Women showed higher medial prefrontal cortex (PFC) drug cue reactivity while men showed higher frontal eye field (FEF)/dorsolateral PFC (dlPFC) drug reappraisal as associated with lower cue-induced drug craving. In women, drug cue reactivity was higher during the follicular phase in the FEF/dlPFC, whereas drug reappraisal was higher during the luteal phase in the anterior PFC/orbitofrontal cortex. The more the estradiol during the follicular versus luteal phase (Δ), the higher the Δdrug cue reactivity in the ventromedial PFC (vmPFC), which also correlated with higher Δdrug craving (observed also in the inferior frontal gyrus). The more the Δestradiol, the lower the Δdrug reappraisal in the vmPFC, anterior PFC, and striatum. Conversely, during the luteal versus follicular phase, the Δprogesterone/estradiol ratio was positively associated with Δdrug reappraisal in the dlPFC. CONCLUSIONS: Compared with men with HUD, women with HUD/CUD show more corticostriatal drug cue reactivity and less PFC drug reappraisal activity, an effect driven by the follicular compared with the luteal phase and directly related to craving and fluctuations in estrogen and progesterone, with the former constituting a vulnerability and the latter a protective factor, providing insights for developing precisely timed and hormonally informed treatments for women with HUD/CUD.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Huang Y, Butelman ER, Ceceli AO, et al. Sex and Hormonal Effects on Drug Cue Reactivity and Its Regulation in Human Addiction. Biol Psychiatry. 2025. PMID: 40441339. doi:10.1016/j.biopsych.2025.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。